Clinical Roundup

Clinical Roundup

Dysfunctional white blood cells linked to heightened melanoma risk

Mayo Clinic study has found that 8 million to 10 million Americans over age 40 have an overabundance of cloned white blood cells, or lymphocytes, that hamper their immune systems. Although many who have this condition—called monoclonal B-cell lymphocytosis—do not experience any symptoms, a recent study shows they may have an elevated risk for several health complications, including melanoma. 
Clinical Roundup

Dexamethasone reduces infusion-related reactions in patients with EGFR-mutated NSCLC treated with intravenous Rybrevant

Johnson & Johnson announced results from the open-label phase II SKIPPirr study, which evaluated additional prophylactic strategies to reduce the incidence of infusion-related reactions with intravenous Rybrevant (amivantamab-vmjw) in patients with advanced non-small cell lung cancer with epidermal growth factor receptor exon 19 deletions or L858R substitution mutations.